Answers are grounded in this paper and cite their sources.
Objective: This systematic review and meta-analysis evaluated the association between circulating non-coding RNA (ncRNA) expression and prognosis after acute ischemic stroke (AIS). Methods: Seven databases were searched from inception to 31 August 2026. Observational studies reporting prognostic outcomes after AIS were included. Study quality was assessed using the Newcastle–Ottawa Scale. Adjusted odds ratios (ORs) and hazard ratios (HRs) were preferentially extracted; HRs were reconstructed from Kaplan–Meier curves when necessary. Findings were synthesized narratively, with random-effects meta-analysis performed for comparable studies. Results: Thirty-six studies involving 5649 patients were included. For poor functional outcome, five studies of continuous microRNA (miRNA) expression were pooled after standardization to a 1-SD change toward the adverse expression direction (OR = 1.33, 95% CI: 1.05–1.69; I2 = 62.0%). Three studies of categorized miRNA expression showed an association between adverse expression categories and poor functional outcome (OR = 3.04, 95% CI: 1.66–5.53; I2 = 34.4%). Eight studies of categorized long non-coding RNA expression showed an association between adverse expression categories and shorter recurrence-free survival (HR = 2.29, 95% CI: 1.80–2.92; I2 = 0%). Two studies of continuous miRNA expression yielded a pooled OR of 2.59 for post-stroke depression (95% CI: 1.60–4.21; I2 = 0%). Individual studies also reported associations with cognitive impairment, symptomatic intracerebral hemorrhage, and mortality. Conclusions: Circulating ncRNA expression was associated with several prognostic outcomes after AIS. These findings require prospective validation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: